Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has enabled better prognosis for patients with peritoneal surface malignancies. However, in older age groups, short -and long-term outcomes are still perceived as poor. We evaluated patients aged 70 and over and determi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cheng Ernest, Shamavonian Raphael, Mui Jasmine, Hayler Raymond, Karpes Josh, Wijayawardana Ruwanthi, Barat Shoma, Ahmadi Nima, Morris David L.
Format:	Artigo
Idioma:	Inglês
Publicat:	De Gruyter 2023-04-01
Col·lecció:	Pleura and Peritoneum
Matèries:	age factors cytoreductive surgery hyperthermic intraperitoneal chemotherapy pseudomyxoma peritonei survival analysis
Accés en línia:	https://doi.org/10.1515/pp-2022-0202
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!